Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...
Global Influenza Diagnostics Market OverviewThe global influenza diagnostics market is projected to expand at a CAGR of 5–8% over the next five years. Market growth is fueled by the rising prevalence ...
News-Medical.Net on MSN
New rapid PCR method detects Salmonella in food within hours
Researchers develop a molecular testing-based fast-throughput method for the rapid and early detection of Salmonella ...
A newly cleared point-of-care test will enable rapid identification of whooping cough, according to a press release from ...
Medical Device Network on MSN
Roche’s test for Bordetella infections gains FDA clearance
Roche’s point-of-care polymerase chain reaction (PCR) test for pertussis and other Bordetella infections has received ...
1don MSN
Is the H3N2 Flu Strain Setting Up Patients for COVID: Researchers Document Unusual Double Infection
Doctors have documented a rare case of a health worker catching H3N2 flu and then COVID-19 11 days later, just as H3N2 ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...
France becomes Seegene's ninth overseas sales subsidiary and third in Europe, following Italy and Germany - The country ranks as Europe's second-largest molec ...
The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback